KPMA opens membership to foreign drug companies.

Published: 1999-04-01 17:25:00

Updated: 1999-04-01 17:25:00

The KPMA decided in the executive meeting on March 24 that the eligibility for KPMA membership widely opened to the foreign multinational drug companies regardless of the manufacturing facility located in Korea if their parent companies had their production facilities or research laboratories in ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK